PP2A - Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Targeting PP2A to tackle cancers: Rappta closes €9m Series A round

PP2A
PP2A is a serine/threonine phosphatase, an enzyme involved in causing cancer progression Credit: Shutterstock.